Cempra Holdings LLC Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 10 of 10 Posts
Cempra Plunges To 52-Week Low, Shire Drug Label Expanded
Article By: Arpita Dutt Friday, December 30, 2016 10:33 AM EDT
It was a relatively slow week for pharma stocks though a couple of companies suffered regulatory setbacks with the FDA issuing complete response letters (CRLs) for their regulatory applications.
In this article: AMPH, AZN, BMY, CEMP, MRK, MYL, SHPG
Read
Street Check: Analyst Made The Right Call On Cempra's Drug
Article By: The Fly Thursday, December 29, 2016 11:37 AM EDT
Cempra announced Thursday that the FDA had decided not to approve its solithromycin drug for community-acquired bacterial pneumonia in the near-term.
In this article: CEMP
Read
Jefferies Sees 'Attractive Buying Opportunities' In Biotech
Article By: The Fly Tuesday, October 18, 2016 10:16 AM EDT
The Jefferies Biotechnology team sees "attractive buying opportunities" amidst the pre-election weakness. They recommend using the weakness to buy select names ahead of a potential improvement in sentiment.
In this article: IMMU, ALKS, CELG, GILD, MDCO, VRTX, CEMP, ALDR, RARE
Read
Short Setups Looking Nice.... Really Nice
Article By: Ryan Mallory Tuesday, March 15, 2016 1:40 PM EDT
Yeah, I know, the bulls, even with today's weakness, still have a firm hold on this market.
In this article: ADS, BBY, F, FLT, GRA, HRS, OSK, TXN, LNG, AMGN, AMZN, CELG, EBAY, ETFC, MU, TSLA, CEMP, YELP, AMBA, WDAY, ABBV, ZG
Read
Insiders Are Loading Up On These 3 Attractive Small Cap Stocks
Article By: Bret Jensen Tuesday, November 3, 2015 6:38 PM EDT
The October rally in stocks seems to have passed over the high beta parts of the market, keeping many small cap stocks’ share prices low.
In this article: PEB, ACAT, CEMP
Read
Chart Of The Day - Cempra (CEMP)
Article By: Jim Van Meerten Tuesday, January 6, 2015 12:59 AM EDT
Cempra Holdings, LLC is a pharmaceutical company engaged in developing antibiotics for the treatment of bacterial infectious diseases. Since the Trend Spotter signaled a buy on 11/26 the stock gained 69.65%,
In this article: CEMP
Read
Morning Call For December 31, 2014
Article By: Jim Van Meerten Wednesday, December 31, 2014 8:19 AM EDT
March E-mini S&Ps (ESH15 +0.13%) this morning are up +0.12% and European stocks are up +0.25% in thin holiday trade. Many European equity markets close early today and U.S. and all European markets will be closed tomorrow for New Year's day.
In this article: MON, CEMP, APP, GSAT, HNH, GRUB
Read
Cempra Poised To Join Antibacterial Drug Acquisition Rumor Buzz With Upcoming Data Release
Article By: Scott Matusow Monday, November 24, 2014 12:28 PM EDT
Cempra Pharmaceuticals expects top-line data release for community acquired bacterial pneumonia by the end of Q1'15. With the very recent Tetraphase acquisition rumor buzz, Cempra is certain to join the acquisition buzz fray if its data release proves positive.
In this article: CBST, CEMP, TTPH
Read
Thinking Differently About Ebola Virus Disease: WBB Securities' Steve Brozak
Article By: The Life Sciences Report Friday, November 14, 2014 6:49 AM EDT
Mdtech analyst that has allowed the WBB Securities cofounder to develop a reasoned perspective on how West Africa's Ebola epidemic might be humanely halted. Brozak also mentions small-cap names that could considerably enhance investors' portfolios.
In this article: GSK, JNJ, NBS, BCRX, OMER, TKMR, CEMP, SRPT, CMRX, TTPH, NAVB
Read
Steve Brozak: Big-Picture Biotech Stocks Rule The Future
Article By: The Life Sciences Report Friday, September 5, 2014 3:50 PM EDT
When Steve Brozak performs diligence on biotech stocks, he's always looking for an angle. Brozak, president and managing director at WBB Securities, wants to see how new technology platforms and novel ideas fit into tomorrow's healthcare system.
In this article: CAH, JNJ, MRK, PFE, NBS, CLDX, OMER, ATHX, CEMP
Read
1 to 10 of 10 Posts